Scientists know that particular nascent chains, or unfinished proteins attached to ribosomes, can regulate ribosomal activity. They have even been observed to interfere with antibiotics by manipulating ribosomal activity in bacteria. The exact mechanisms behind this process have been unclear – that’s why University of Illinois Chicago researchers reported a method that will provide breakthroughs in the level of detail observed with these ribosome-peptide-drug interactions.
“The challenge has been to see up close the structure of the ribosome and the exit tunnel in the presence of the nascent peptides because, in nature, the ribosome is very quick for us to capture images or conduct experiments,” says senior author Yury Polikanov, associate professor of biological sciences at the College of Liberal Arts and Sciences. “Until the advent of this new method, we’ve essentially been blinded from seeing what is happening in the active site of the ribosome at this critical moment in time.”
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
This new method, reported in Nature Chemistry, allows scientists to attach peptides to transfer RNAs, or tRNAs, to further understand atomic-level ribosomal structures and the shapes these peptides take inside the ribosome.
To begin, Polikanov and his colleague Egor Syroegin, PhD Candidate in biological sciences at UIC, used a method called native chemical ligation to fuse custom peptides with tRNA to yield a peptidyl-tRNA. “Obtaining tRNA molecules linked to peptides, similar to those inside the ribosome during protein synthesis, has remained a dream of many researchers in the field for almost two decades,” explains Polikanov. “This has been extremely challenging because there are no enzymes that can directly attach peptides to a tRNA.”
“The method has been used for a long time in chemistry, but it has never been applied in this way. It’s mimicking nature, basically, and with our advanced imaging experience, we are now seeing how nature works at a high resolution,” says Syroegin.
This approach allowed the team to analyze the details of these various peptidyl-tRNAs, with surprising insights into the mechanisms behind the ribosome’s catalytic center. “We saw that depending on the sequence, different peptides can form different shapes or folds within the ribosomal tunnel, and we can synthesize different peptides of different sequences and then follow their shape very precisely, because of the high resolution of our structures,” states Syroegin. “So now, we can very confidently say that ‘these peptides, of this sequence, have this shape’ or ‘another peptide has another shape.’ That’s important because nascent peptide folding determines whether drugs would arrest ribosome or not.”
“This method opens countless avenues for structural and functional studies aimed at understanding the mechanisms of ribosome functioning, as well as sequence-specific ribosome stalling induced by certain antibiotics,” says Polikanov.